BRD4 (BD1/2) BET bromodomain inhibitor

wound-heal. at 1 mpk QD, bell-shaped pharm.

from phenotypic screen (MDM2 inhibitor hit)

Nat. Chem. Biol., Jan. 18, 2021

Novartis (NIBR), Basel, CH

Chemical structure of molecule NVS-BET-1

The Novartis BET bromodomain inhibitor, NVS-BET-1, is a new chemotype of BRD4 (BD1 and BD2) inhibitor. While we recently highlighted a few high-profile, selective bromodomain inhibitors from AbbVie and…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: